Linked Life Data

15976066

Source:http://linkedlifedata.com/resource/pubmed/id/15976066

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-7-20
pubmed:abstractText
Busulfan (BU) pharmacokinetics (PK) are shown to be highly variable and thus their evaluation is critical for the success of hematopoietic stem cell transplantation (HST) in Caucasians. However, there are no data available for Japanese patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0368-2811
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
400-3
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15976066-Administration, Oral, pubmed-meshheading:15976066-Adult, pubmed-meshheading:15976066-Aged, pubmed-meshheading:15976066-Antineoplastic Agents, Alkylating, pubmed-meshheading:15976066-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15976066-Busulfan, pubmed-meshheading:15976066-Cyclophosphamide, pubmed-meshheading:15976066-Female, pubmed-meshheading:15976066-Hematologic Neoplasms, pubmed-meshheading:15976066-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:15976066-Humans, pubmed-meshheading:15976066-Male, pubmed-meshheading:15976066-Middle Aged, pubmed-meshheading:15976066-Prospective Studies, pubmed-meshheading:15976066-Transplantation, Autologous, pubmed-meshheading:15976066-Treatment Outcome, pubmed-meshheading:15976066-Vidarabine, pubmed-meshheading:15976066-Whole-Body Irradiation
pubmed:year
2005
pubmed:articleTitle
An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
pubmed:affiliation
First Department of Internal Medicine, Fukuoka University School of Medicine, Nanakuma 7-45-1, Jonan-ku, Fukuoka 814-0180, Japan. yasushi@fukuoka-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't